KAPA
KAPA
AMEX · Biotechnology

Kairos Pharma Ltd

$0.62
+0.03 (+4.24%)
As of Feb 8, 2:28 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 5.65M 5.72M 5.36M
Net Income 307.3K 283.7K 353.7K
EPS
Profit Margin 5.4% 5.0% 6.6%
Rev Growth +24.0% +14.6% +14.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 3.26M 3.51M 3.59M
Total Equity 4.61M 3.84M 3.90M
D/E Ratio 0.71 0.92 0.92
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 445.8K 473.3K 433.9K
Free Cash Flow 346.8K 407.6K 312.1K